Goldman Sachs analyst Matthew Sykes downgraded Cytek Biosciences Inc (NASDAQ:CTKB) stock rating from Buy to Sell and reduced the price target to $4.50 from the previous $7.00. The downgrade reflects ...

The significant players operating in the global Microbiome Sequencing Services Market are Baseclear B.V., Clinical Microbiomics A/S, EPIBIOME, Merieux Nutrisciences Corporations, Metabiomics Corp., ...

It will provide two Asian American, Native Hawaiian or Pacific Islander filmmakers with post-production grants of $50,000 ...

Interpace Biosciences, Inc. ("Interpace” or the "Company”) (OTCQX: IDXG) today announced preliminary financial and business results for the fiscal year and fourth quarter ended December 31, 2024.

The Dow traded down 0.04% to 44,865.23 while the NASDAQ climbed 1.15% to 19,908.53. The S&P 500 also rose, gaining, 0.57% to 6,105.94. Exxon Mobil Corporation XOM reported better-than-expected ...

In a report released today, Jonathan Wolleben from JMP Securities maintained a Buy rating on Pharvaris (PHVS – Research Report), with a price ...

Ipsen and Sutro Biopharma entered a global licensing deal for STRO-003, an ADC targeting ROR1, overexpressed in cancers, ...

European shares were mostly higher today. The eurozone's STOXX 600 rose 0.3%, Germany's DAX 40 gained 0.2% and France's CAC 40 climbed 0.3%. Spain's IBEX 35 Index fell 0.1%, while London's FTSE 100 ...

A midair collision between an American Airlines flight and an Army helicopter over the Potomac River killed all 67 people on the two aircraft, officials said Thursday, leaving investigators to piece ...

Fructosamine Test IndustryThe global fructosamine test indutry was valued at around USD 266.3 million in 2023 and is poised to exhibit a CAGR of 3.8% during the forecast period. Accordingly, total ...